ClinicalTrials.govpublic full text
A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
asthma, severe eosinophilic asthma, extension study, expanded access, safety, mepolizumab, eosinophils, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 912317
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.